Table 1. Patients’ clinicopathological characteristics#.
| Variables | Value 1 | Value 2 |
|---|---|---|
| Age, years | 51 [46–61] | 53 [11] |
| TB (ìmol/L) | 12.5 [10.2–16.6] | 14 [6.5] |
| Prothrombin time (s) | 11.6 [10.9–12.5] | 11.7 [1.1] |
| Serum albumin (g/L) | 44.0 [39.0–46.0] | 43 [5] |
| Glutamic pyruvic transaminase (ì/L) | 34 [23–50] | 47 [47] |
| GGT (ì/L) | 59 [32–120] | 102 [117] |
| Tumor size (cm) | 5.8 [4.0–7.5] | 6.1 [2.6] |
| Sex (male vs. female) | 72 vs. 35 | 67.3 vs. 32.7 |
| Cirrhosis (positive vs. negative) | 14 vs. 93 | 13.1 vs. 86.9 |
| HBV DNA, copies/mL (≤103 vs. >103) | 22 vs. 85 | 20.6 vs. 79.4 |
| CA19-9, ì/mL (≤37 vs. >37) | 52 vs. 55 | 48.6 vs. 51.4 |
| AFP, ng/mL (≤20 vs. >20) | 82 vs. 25 | 76.6 vs. 23.4 |
| Tumor number (solidary vs. multiple) | 100 vs. 7 | 93.5 vs. 6.5 |
| Tumor location (single lobe vs. multiple lobes) | 91 vs.16 | 85.0 vs. 14.5 |
| Liver resection (local vs. anatomical) | 44 vs. 63 | 41.1 vs. 58.9 |
| Tumor capsule (negative vs. positive) | 92 vs. 15 | 86.0 vs. 14.0 |
| Micro tumor thrombus (yes vs. no) | 22 vs. 85 | 20.6 vs. 79.4 |
| Hilar lymph nodes (negative vs. positive) | 97 vs. 10 | 90.7 vs. 9.35 |
| Histologic differentiation (well vs. poor) | 70 vs. 37 | 65.4 vs. 34.6 |
| Adjuvant chemotherapy (yes vs. no) | 36 vs. 71 | 33.6 vs. 66.4 |
#, value 1: continuous variables are shown as median [IQR], categorical variables are shown as no.; value 2: continuous variables are shown as mean [SD], categorical variables are shown as %. IQR, inter-quartile range; SD, standard deviation; HBV, hepatitis B virus; TB, total bilirubin; GGT, gamma-glutamyl transpeptidase; CA19-9, carbohydrate antigen 19-9; AFP, alpha-fetoprotein.